TYK Medicines schedules board meeting to review interim results, consider dividendPUBT·2 days ago, 04:16 AM02410+705.00%
The Great Reshuffling at the Fringes of the Hong Kong MarketGlobal Report·Aug 4 at 04:17 AM01333-190.00%012890.00%
TYK Medicines sues Huiyu Pharma over disputed TY-9591 cooperation dealPUBT·Jul 22 at 09:52 AM02410+705.00%688553+759.00%
Tongyuan Kang Medicine-B falls over 2% in Hong Kong tradingHK Stock Market Update·Jul 21 at 08:50 PM02410+705.00%
TYK Medicines prices private placement of 63,222,744 H shares at HK$ 7.3 eachPUBT·Jul 21 at 06:22 AM02410+705.00%
TYK Medicines shareholders pass Articles of Association amendments at AGMPUBT·Jun 23 at 05:44 AM02410+705.00%
TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes LoomTip Ranks·Mar 30 at 04:18 AM159837+554.00%513060+502.00%
"Performance" TYK MEDICINES reported a full-year loss narrowed to 300 million RMB and will not distribute dividendsAASTOCKS·Mar 30 at 03:45 AM516500+612.00%159316+478.00%
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR MeetingTip Ranks·Mar 25 at 10:23 AM02410+705.00%FBT+230.00%
TYK MEDICINES has completed the full circulation of H sharesAASTOCKS·Mar 4 at 02:38 AM02410+705.00%513700+574.00%
